Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden flag Sweden · Delayed Price · Currency is SEK
64.30
-0.50 (-0.77%)
Nov 4, 2026, 5:29 PM CET

Devyser Diagnostics AB Revenue

Devyser Diagnostics AB had revenue of 59.70M SEK in the quarter ending September 30, 2026, with 5.85% growth. This brings the company's total for the last twelve months to 253.70M, up 4.49% year-over-year. In the year 2025, Devyser Diagnostics AB had annual revenue of 250.50M with 15.49% growth. That makes Devyser Diagnostics AB the 32,278th largest company in the world by revenue and 415th in Sweden.

Revenue (ttm)
253.70M
Revenue Growth
+4.49%
P/S Ratio
4.23
Revenue / Employee
2.31M
Employees
110
Market Cap
1.09B

Revenue Chart

Revenue by Geography

  • Italy 149.80M 37.2%
  • Europe (Excluding Sweden and Italy), Middle East and Africa 84.50M 21.0%
  • Group Wide 74.50M 18.5%
  • Germany 32.20M 8.0%
  • United States 31.00M 7.7%
  • Sweden 18.60M 4.6%
  • Asia-Pacific 7.40M 1.8%
  • North and South America(excluding Us) 4.40M 1.1%
Fiscal year ended Dec 31, 2025 See the full Devyser Diagnostics AB breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025250.50M33.60M15.49%
Dec 31, 2024216.90M47.60M28.12%
Dec 31, 2023169.30M42.70M33.73%
Dec 31, 2022126.60M33.12M35.43%
Dec 31, 202193.48M27.79M42.31%
Dec 31, 202065.69M1.39M2.16%
Dec 31, 201964.30M16.16M33.55%
Dec 31, 201848.15M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
BICO Group AB1.50B
C-Rad AB417.60M
Paxman AB365.91M
Mentice AB303.13M
Bactiguard Holding AB216.59M
Sedana Medical AB198.44M
OssDsign AB163.80M
Senzime AB106.35M
Revenue Rankings